Neonatal HIV seroprevalence studies. A critique of national and international practices.
Isaacman
S H
SH
John Marshall Law School.
Miller
L A
LA
D035041:Anonymous Testing; D026686:Beneficence; D032781:Codes of Ethics; D030881:Disclosure; D004992:Ethics, Medical; D035082:Federal Government; D005260:Female; D033161:Government Regulation; D015658:HIV Infections / Q000151:congenital* / Q000453:epidemiology; D015528:HIV Seroprevalence / Q000639:trends*; D006801:Humans; D007231:Infant, Newborn; D007258:Informed Consent / Q000331:legislation & jurisprudence; D038622:Internationality; D007872:Legal Guardians; D008297:Male; D015997:Neonatal Screening / Q000331:legislation & jurisprudence*; D033281:Nontherapeutic Human Experimentation; D026684:Personal Autonomy; D037841:Pregnant People; D035842:Research Subjects; D035502:Trust; D014481:United States / Q000453:epidemiology; D035862:Vulnerable Populations